Weekly Wellness Spotlight

As we say goodbye to January, National Glaucoma Awareness Month, let’s take a look at a study involving Omega 3’s and IOP:

https://tvst.arvojournals.org/Article.aspx?articleid=2680625

In this study, 105 individuals 18 years of age and older were randomized to take one of the following: a krill oil supplement containing 945 mg/d of EPA and 510 mg/d of DHA, a fish oil supplement containing 1000 mg/d EPA and 500 mg/d DHA, a fish oil supplement containing 900 mg/d EPA and 600 mg/d DHA, an essential fatty acid supplement containing 900 mg/d EPA with 600 mg/d DHA and 900 mg/d ALA, or a placebo supplement containing 1500 mg/d of olive oil for three months. Intraocular pressure was measured at baseline and at the three month follow-up visit.
Results showed that omega-3 fatty acid supplementation significantly reduced intraocular pressure in adults consuming a Western diet. This is the first study that demonstrates that fish oil supplementation can modulate intraocular pressure in humans, which can reduce the need for topical IOP-lowering agents.
Incorporating more omega 3’s into the diets of our patients has far reaching benefits beyond that of dry eye therapy and retinal health.
Save the Date!
12th Annual Nutrition and the Eye Symposium
12 hrs CE/CEE
April 13 & 14, 2019
References: